Riester Anna, Fischer Evelyn, Degenhart Christoph, Reiser Maximilian F, Bidlingmaier Martin, Beuschlein Felix, Reincke Martin, Quinkler Marcus
Medizinische Klinik und Poliklinik IV (A.R., E.F., M.B., F.B., M.R.) and Klinische Radiologie (C.D., M.F.R.), Klinikum der Ludwig-Maximilians-Universität München, D-80336 München, Germany; and Clinical Endocrinology (M.Q.), Charité Campus Mitte, Charité University Medicine Berlin, D-10117 Berlin, Germany.
J Clin Endocrinol Metab. 2014 Jun;99(6):E1035-9. doi: 10.1210/jc.2013-3789. Epub 2014 Mar 6.
Adrenal venous sampling (AVS) is used to distinguish bilateral from unilateral primary aldosteronism (PA). Due to its limited availability, clinical prediction scores have been proposed to diagnose unilateral disease without AVS.
Our goal was to test 2 recently proposed predictors of unilateral PA: 1) a clinical prediction score using imaging, serum potassium, and glomerular filtration rate and 2) the combination of visible unilateral adenoma on imaging and age <40 years.
We used the data of all patients with PA of the prospective German Conn's Registry treated in Munich and Berlin since 2008.
Of 205 patients with PA, 194 had a successful AVS and were included.
Parameters were compared between patients with lateralized and nonlateralized AVS. Specificity and sensitivity of the proposed predictors were calculated.
A total of 130 patients (67%) had unilateral PA according to AVS. Patients with unilateral PA showed a significantly lower estimated glomerular filtration rate compared with patients with bilateral disease (P < .05). The cohorts differed significantly in potassium supplementation, serum potassium, baseline and post-saline plasma aldosterone, baseline aldosterone to renin ratio, and adenoma in imaging. The proposed prediction score had a sensitivity of 46% (58 of 127) and a specificity of 80% (53 of 66). In patients below 40 years (n = 28), the prediction score achieved a specificity of 100%; however, relying only on imaging in this young cohort, the specificity dropped to 83%.
The suggested prediction score has high accuracy only in young patients but cannot substitute for AVS in the elderly.
肾上腺静脉采血(AVS)用于区分双侧与单侧原发性醛固酮增多症(PA)。由于其应用受限,已提出临床预测评分来在不进行AVS的情况下诊断单侧疾病。
我们的目标是测试最近提出的两种单侧PA预测指标:1)使用影像学、血清钾和肾小球滤过率的临床预测评分;2)影像学上可见的单侧腺瘤与年龄<40岁的组合。
我们使用了自2008年以来在慕尼黑和柏林接受治疗的前瞻性德国Conn登记处所有PA患者的数据。
205例PA患者中,194例成功进行了AVS并被纳入研究。
比较了AVS定位和未定位患者的参数。计算了所提出预测指标的特异性和敏感性。
根据AVS,共有130例患者(67%)患有单侧PA。与双侧疾病患者相比,单侧PA患者的估计肾小球滤过率显著更低(P <.05)。两组在补钾、血清钾、盐水负荷前后血浆醛固酮、基线醛固酮与肾素比值以及影像学上的腺瘤方面存在显著差异。所提出的预测评分敏感性为46%(127例中的58例),特异性为80%(66例中的53例)。在40岁以下的患者(n = 28)中,预测评分的特异性达到100%;然而,仅依靠该年轻队列中的影像学检查,特异性降至83%。
所建议的预测评分仅在年轻患者中具有较高准确性,但在老年患者中不能替代AVS。